Pimasertib Versus Dacarbazine in Patients With UnresectableNRAS-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover

Lebbe, Celeste; Dutriaux, Caroline; Lesimple, Thierry; Kruit, Willem; Kerger, Joseph; Thomas, Luc; Guillot, Bernard; de Braud, Filippo; Garbe, Claus; Grob, Jean-Jacques; Loquai, Carmen; Ferraresi, Virginia; Robert, Caroline; Vasey, Paul; Conry, Robert; Isaacs, Richard; Espinosa, Enrique; Schueler, Armin; Massimini, Giorgio; Dreno, Brigitte

dc.contributor.author	Garbe, Claus
dc.date.accessioned	2020-12-28T09:31:28Z
dc.date.available	2020-12-28T09:31:28Z
dc.date.issued	2020
dc.identifier.issn	2072-6694
dc.identifier.uri	http://hdl.handle.net/10900/110938
dc.language.iso	en	de_DE
dc.publisher	Mdpi	de_DE
dc.relation.uri	http://dx.doi.org/10.3390/cancers12071727	de_DE
dc.subject.ddc	610	de_DE
dc.title	Pimasertib Versus Dacarbazine in Patients With UnresectableNRAS-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover	de_DE
dc.type	Article	de_DE
utue.quellen.id	20200929220116_00714
utue.personen.roh	Lebbe, Celeste
utue.personen.roh	Dutriaux, Caroline
utue.personen.roh	Lesimple, Thierry
utue.personen.roh	Kruit, Willem
utue.personen.roh	Kerger, Joseph
utue.personen.roh	Thomas, Luc
utue.personen.roh	Guillot, Bernard
utue.personen.roh	de Braud, Filippo
utue.personen.roh	Garbe, Claus
utue.personen.roh	Grob, Jean-Jacques
utue.personen.roh	Loquai, Carmen
utue.personen.roh	Ferraresi, Virginia
utue.personen.roh	Robert, Caroline
utue.personen.roh	Vasey, Paul
utue.personen.roh	Conry, Robert
utue.personen.roh	Isaacs, Richard
utue.personen.roh	Espinosa, Enrique
utue.personen.roh	Schueler, Armin
utue.personen.roh	Massimini, Giorgio
utue.personen.roh	Dreno, Brigitte
dcterms.isPartOf.ZSTitelID	Cancers	de_DE
dcterms.isPartOf.ZS-Issue	Article 1727	de_DE
dcterms.isPartOf.ZS-Volume	12 (7)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE